EichorEICHOR
Location: Suita Synced from ClinicalTrials.gov · August 08, 2026

Clinical studies recruiting near Suita

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

Surgery Plus Chemo Versus Chemoradiotherapy Followed by Surgery Plus Chemo for Locally Recurrent Rectal Cancer
Phase 3 · Osaka University Graduate School of Medicine · National Cancer Center Hospital East · NCT04288999Recombinant Factor VIIa (rFVIIa) for Hemorrhagic Stroke Trial - Part 2
Phase 3 · National Cerebral and Cardiovascular Center · Joseph Broderick, MD · NCT07227246This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide W
Phase 3 · The University of Osaka Hospital · Pfizer · NCT07028853Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did Not Achieve pCR (MK-2870-012)
Phase 3 · The University of Osaka Hospital ( Site 3416) · Merck Sharp & Dohme LLC · NCT06393374This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in
Phase 3 · The University of Osaka Hospital · Pfizer · NCT06758401A Non-Interventional Study PASS to Characterize Secondary Malignancies of Tcell Origin Following Tisagenlecleucel Therap
Phase N/A · Novartis Investigative Site · Novartis Pharmaceuticals · NCT07378969LY4268989 in Adults With Moderately to Severely Active Ulcerative Colitis
Phase 2 · The University of Osaka Hospital · Eli Lilly and Company · NCT07415044A Study of Rapcabtagene Autoleucel in Active, Refractory Systemic Lupus Erythematosus (SLE) or Lupus Nephritis (LN) Pati
Phase 2 · Novartis Investigative Site · Novartis Pharmaceuticals · NCT06581198A Study to Learn About the Study Medicine Called PF-08046054/SGN-PDL1V Versus Docetaxel in Adult Participants With Previ
Phase 3 · Osaka University Hospital · Pfizer · NCT07144280A Study to Learn How PF-06821497 (Mevrometostat) Works in Men With Metastatic Castration-resistant Prostate Cancer.
Phase 3 · The University of Osaka Hospital · Pfizer · NCT06629779A Study to Evaluate Finerenone on Clinical Efficacy and Safety in Patients With Heart Failure Who Are Intolerant or Not
Phase 3 · FIN-57007, Suita, Osaka · Colorado Prevention Center · NCT06033950TriClip Japan Post-Approval Study
Phase N/A · National Cerebral & Cardiovascular Center Hospital · Abbott Medical Devices · NCT07509658Symbiotic-GU-08: A Study to Learn About the Medicine Called PF-08634404 Dosed Alone and in Combination With Other Antica
Phase 1/Phase 2 · The University of Osaka Hospital · Pfizer · NCT07227415TBE Zone 2 PMS in Japan
Phase N/A · W.L.Gore & Associates · NCT07049913A Study of the Efficacy and Safety of DMX-200 in Patients With FSGS Who Are Receiving an ARB
Phase 3 · The University of Osaka Hospital · Dimerix Bioscience Pty Ltd · NCT05183646A Study to Evaluate the Effect of Aficamten in Pediatric Patients With Symptomatic Obstructive Hypertrophic Cardiomyopat
Phase 2/Phase 3 · National Cerebral and Cardiovascular Center · Cytokinetics · NCT06412666A Study to Evaluate Safety and Efficacy of KarXT + KarX-EC as a Treatment for Psychosis Associated With Alzheimer's Dise
Phase 3 · Local Institution - 0040 · Bristol-Myers Squibb · NCT06947941Long-term Safety and Efficacy Extension Study for Participants With Advanced Tumors Who Are Currently on Treatment or in
Phase 3 · The University of Osaka Hospital ( Site 3168) · Merck Sharp & Dohme LLC · NCT03486873LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have C
Phase 3 · The University of Osaka Hospital · Boehringer Ingelheim · NCT06632457Early Treatment With a Sodium-glucose Co-transporter 2 Inhibitor in High-risk Patients With Acute Heart Failure
Phase 3 · National Cerebral and Cardiovascular Center Hospital · Juntendo University · NCT05392764Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease o
Phase 3 · Clinical Trial Site · Alnylam Pharmaceuticals · NCT07181109A Study to Evaluate the Efficacy and Safety of Dapirolizumab Pegol in Study Participants With Moderately to Severely Act
Phase 3 · Sl0044 20277 · UCB Biopharma SRL · NCT06617325Phase 2 Study Evaluating Rapcabtagene Autoleucel in Participants With Severe Active GPA or MPA
Phase 2 · Novartis Investigative Site · Novartis Pharmaceuticals · NCT06868290Study of Opevesostat (MK-5684) Versus Alternative NHA in mCRPC (MK-5684-003)
Phase 3 · The University of Osaka Hospital ( Site 0911) · Merck Sharp & Dohme LLC · NCT06136624A Study of ASP2138 Given by Itself or Given With Other Cancer Treatments in Adults With Stomach Cancer, Gastroesophageal
Phase 1 · The University of Osaka Hospital · Astellas Pharma Global Development, Inc. · NCT05365581A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Signif
Phase 2/Phase 3 · The University of Osaka Hospital · Pfizer · NCT06989437TRITON-PN: A Study to Evaluate the Efficacy and Safety of Nucresiran in Patients With Hereditary Transthyretin Amyloidos
Phase 3 · Clinical Trial Site · Alnylam Pharmaceuticals · NCT07223203Evaluation Using FAPI-PET Targeting Cancer-associated Fibroblasts
NA · Osaka University Hospital · Tadashi Watabe · NCT05442151A Study of Sacituzumab Tirumotecan (MK-2870) as a Single Agent and in Combination With Pembrolizumab (MK-3475) Versus Tr
Phase 3 · The University of Osaka Hospital ( Site 2476) · Merck Sharp & Dohme LLC · NCT06312176A Study to Investigate the Efficacy, Safety and Tolerability of Remibrutinib Versus Placebo in Adult Patients With Gener
Phase 3 · Novartis Investigative Site · Novartis Pharmaceuticals · NCT06744920
Look up another city
Look up another condition
Eichor
Clinical intelligence from public evidence
Use of Eichor is governed by our Terms of Use · Privacy Policy
© 2026 Biomedistats LLC (dba Eichor)

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.